@PiaGarciaHere LOOK: FDA Director General Eric Domingo shows which vaccines have obtained an EUA
@PiaGarciaHere FDA Director General Eric Domingo reminds the public of the amended interval between the second dose of the COVID-19 vaccine and the booster dose
@PiaGarciaHere FDA: Base po ito sa recommendation of the DOST vaccine expert panel, at ito ay dahil nakita nila...na meron pong waning protection after a few months after the second dose
@PiaGarciaHere FDA: Yung pagbibigay ng booster is expected to increase the antibody response against the new variants
@PiaGarciaHere FDA: Nakita natin that it is reasonable to believe that the vaccine may be effective to prevent COVID-19 and the benefits outweigh the known potential risks
@PiaGarciaHere FDA on brands that have compassionate special permit: Yung brands na may compassionate special permit ngayon, of course pwedeng magamit ngayon and tinatawag na ma-exhaust yung mga supplies. (1/2)
@PiaGarciaHere FDA on brands that have compassionate special permit: And of course these brands ay nag-submit na rin ng EUA application sa atin. Sumunod din sila sa Molnarz and once ma-comply yung requirements...mabibigyan din sila ng EUA (2/2)
@PiaGarciaHere FDA says the time interval granted between last dose and booster shots is the shortest allowed by experts not just locally but worldwide
@PiaGarciaHere FDA says the booster shots are allowed for all adults 18 and above: Pero syempre po ang DOH ipa-prioritize pa rin ang senior citizens and yung may comorbities at yung may risk factor for developing severe COVID
@PiaGarciaHere FDA says no boosters are available yet for children below 18 years old
FDA: Sa ngayon wala pang application ang DOH, or wala pa silang request to include boosters ng 17 years old and below... Wala pa tayong pina-process na request para sa amendment to include minors sa booster shots
FDA says they are waiting for further information concerning booster shots, including whether further booster shots will be needed
FDA : Ito po malalaman natin as we get more information
FDA on the roll out of vaccines for ages 5-11: Ang alam ko po ay ito ay pinaplano ng NTF at ng DOH na gawin as early as January 2022. Pero depende kung nag-order na sila or kung meron na silang nasecure, nakabili ng supplies and kung ready mag roll out
FDA on whether vaccine manufacturers have submitted information on the efficacy vs the Omicron variant: Wala pa...sa buong mundo naghihintay tayo ng more data on this
FDA: Of course, we expect na dahil bagong variant, ito ay from previous experience pag may bagong variant ay nagkakaroon ng konting pagbaba ang efficacy ng vaccines...pero hindi nawawala completely ang efficacy nito
FDA says companies developing vaccines specifically targeting the Omicron variant will need to apply for an EUA: Anytime magkakaroon ng pagbabago sa bakuna. (1/2)
FDA: Kailangan itong dumaan ulit sa EUA process para mapakita yung scientific evidence that will support the change in the EUA or the change in the product (2/2)
FDA on expected effects of the amended booster schedule: Ine-expect natin ay talagang at least most people who will get the booster will have a sudden increase ng mga antibodies nila. Pero ina-assure tayo ni Sec. Galvez...na there is enough vaccines to go around
NVOC's Dr. Kezia Lorraine Rosario says around 992,000 vaccine doses were administered on Dec. 22. Pushing the total vaccines administered during the second round of the 'Bayanihan, Bakunahan' from Dec. 15-22 to 6.4 million
NVOC also says that submission of data has been slow because of the effects of #OdettePH
NVOC says they expect the administration of booster shots to be slow initially, but would also ramp up
NVOC says the number of people qualified to get booster shots rose because of the amended interval from the final dose: Yung nabakunahan around March to September, ito yung mga individuals na pwede nang mabigyan ng booster dose. (1/2)
NVOC: Ngayon 19 million ito, more or less, and yung nabakunahan pa lang is 1.2 (million), around that number. And ine-expect natin na dadami ito as the days go along (2/2)
NVOC says they are calculating how many doses of the Pfizer vaccine will be needed for children ages 5-11
NVOC says assessment of areas affected by #OdettePH are ongoing, but in some areas vaccination activities have resumed
NVOC says assessment on possible vaccine wastage is ongoing, but they have instructions on what should be done in areas affected by #OdettePH
NVOC says the report on how many vaccines were wasted could be released later today
PH Coast Guard spokesman Commodore Armand Balilo says operations to help those affected by #OdettePH continue: Ang instructions ni Sec. Art Tugade ay gawing round-the-clock at abutin yung mga areas na kailangan abutin at bigyan ng tulong
PCG says they have deployed 9 vessels to bring relief and help residents
PCG says they're looking to repair ports damaged by the storm
PCG on the outpost in Pag-asa Island damaged by #OdettePH: May instructions na po si Admiral Laroya at makikipag-partner sa ating Philippine Coast Guard Auxiliary na gawin ulit yung station sa lalong madaling panahon
DOLE Bureau of Workers and Special Concerns Dir. Atty. Ma. Karina Perida-Trayvilla says as of Dec. 17, around 2 million individuals from the informal sector have been helped by the TUPAD program
DOLE: Nakapag-utilize na tayo ng ₱9.6 billion na budget. Tayo ay umaasa na magiging mataas budget ng TUPAD program para sa 2022
DOLE says AO 117 has instructions to extend work under the TUPAD program from 10 days to 90 days depending on the kind of work of beneficiaries
DOLE said the TUPAD program in areas hit by #OdettePH has started in some areas and will begin in others to help beneficiaries
• • •
Missing some Tweet in this thread? You can try to
force a refresh
@ruthcabal15 DPWH spokesperson Usec. Emerson Benitez: We were able to clear 40 national road sections. Mayroon nalang tayong anim na natira na hindi pa madaanan hanggang ngayon.
@ruthcabal15 DPWH: We were able to initially release ₱100 million for clearing operations
JUST IN: FDA says it has allowed the emergency use of Molnarz, a brand of oral pill molnupiravir that is used to treat mild to moderate COVID-19 cases.
FDA: Ito po ay pinapayagan nating ibigay sa mga pasyente na may mild to moderate COVID... Hindi po ito pwede sa mga severe o nangangailangan na ng oxygen
FDA: Ito ay pwede lamang ibigay sa mga adults 18 years old and above na positive sa COVID-19 and merong risk factors for developing severe illness, katulad ng mga senior citizen o mga may comorbidites
BREAKING: FDA approves Pfizer COVID-19 shots for children aged 5-11. FDA chief Eric Domingo says the government needs to procure a specific dose to be used by younger children.
FDA says the efficacy rate of the Pfizer vaccine among children 5-11 years old is high – above 90%. Also, the seen adverse effects in clinical trials are "very mild." No unusual or important safety signals were seen
UnionBank announces its acquisition of Citigroup's PH consumer banking business.
Deal includes Citi's credit card, personal loans, wealth management, retail deposit segments; about 1,750 Citi employees including senior mgmt. expected to join the bank, it adds | @pplmanuel
@pplmanuel The bank adds it will pay a cash consideration for Citi's PH consumer business's net assets atop a ₱45.3B premium.
UnionBank: Based on the anticipated increase in risk-weighted assets, the required equity is approximately ₱9.7 billion as of 30 June 2021 | @pplmanuel
@pplmanuel UnionBank says the acquisition will be funded by a combination of internal resources, stock rights offering (SRO)
UnionBank: The Bank’s key shareholders – Aboitiz Equity Ventures, Insular Life Assurance, and Social Security System – are fully committed to the SRO | @pplmanuel
UN Environment Goodwill Ambassador and Planet Cora founder @AntoinetteTaus: The Philippines is hit by an average of 20 storms per year. We are the top country in the world that's most at risk from climate change.
@AntoinetteTaus .@AntoinetteTaus: There must be long-term solutions to the climate crisis. It's not just about helping now, but preventing lives from being lost in the future.